ImmunoGen Message Board - Msg: 15092080

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WYD who wrote (3783)	12/28/2000 12:52:02 PM
From: Gary Mohilner	Read Replies (1) of 5665

I spite of Mitch's forecast, the end of the year seems to be passing quietly. Drugrunner on R.B. speculated that a pending partnership based on the ABGX model may be somewhat renegotiated based on recent stock weakness, selling the partner $15 million at say $35 may have been far more desirable then selling them substantially more stock at say $25 today. I'd not be surprised to find the IND's filed, IMGN has previously not announced the filing, but rather waited and announced the approval. While this cuts the P.R. issues from 2 to 1 it eliminates the risk of having to explain delays caused by the FDA. For those who've been long all of 2000, it's been a good year, I believe 2001 will be as good or better. Happy New Year's Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next